Gastric inhibitory polypeptide diagnostic test for detecting...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2405900

Methods and kits for determining whether an individual is susceptible to developing impaired glucose tolerance (IGT), impaired fasting glucose (IFG), or Type-2 diabetes are described. Such methods include administering GIP or GIP variant and nutrient to an individual, measuring the response of the individual and determining whether the individual is susceptible to developing IGT, Type-2 diabetes, or IFG.

L'invention concerne des méthodes et des kits permettant de déterminer si un individu est susceptible de développer une intolérance au glucose (IGT), une glycémie à jeun (IFG), ou des diabètes de type 2. Ces méthodes consistent à administrer un polypeptide inhibiteur gastrique ou un variant de polypeptide inhibiteur gastrique et une substance nutritive à un individu, mesurer la réponse de l'individu et déterminer si cet individu est susceptible de développer une intolérance au glucose (IGT), des diabètes de type 2 ou une glycémie à jeun (IFG).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gastric inhibitory polypeptide diagnostic test for detecting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gastric inhibitory polypeptide diagnostic test for detecting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastric inhibitory polypeptide diagnostic test for detecting... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1874304

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.